| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 39.491 | 31.993 | 18.590 | 17.981 | 22.191 | 21.199 | 22.244 | 21.983 | 22.710 | 22.927 |
| Total Income - EUR | 39.491 | 31.993 | 18.590 | 17.981 | 22.191 | 21.262 | 22.244 | 21.984 | 22.711 | 22.927 |
| Total Expenses - EUR | 10.831 | 10.912 | 10.284 | 22.158 | 11.733 | 10.287 | 6.242 | 7.934 | 7.346 | 12.917 |
| Gross Profit/Loss - EUR | 28.661 | 21.081 | 8.306 | -4.177 | 10.458 | 10.975 | 16.002 | 14.049 | 15.365 | 10.011 |
| Net Profit/Loss - EUR | 27.476 | 20.121 | 7.748 | -4.358 | 9.967 | 10.626 | 15.335 | 13.390 | 14.684 | 9.323 |
| Employees | 2 | 2 | 0 | 0 | 2 | 2 | 0 | 2 | 0 | 2 |
Check the financial reports for the company - Medmida S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 700 | 139 | 60 | 377 | 941 | 347 | 0 | 0 | 0 | 0 |
| Current Assets | 27.174 | 20.478 | 8.160 | 1.878 | 4.590 | 8.798 | 14.383 | 12.729 | 13.899 | 8.650 |
| Inventories | 0 | 0 | 558 | 578 | 752 | 738 | 721 | 1.038 | 1.048 | 0 |
| Receivables | 18.450 | 17.855 | 6.689 | 1.144 | 2.581 | 6.174 | 13.146 | 9.638 | 11.391 | 6.097 |
| Cash | 8.725 | 2.624 | 913 | 156 | 1.256 | 1.886 | 516 | 2.054 | 1.460 | 2.553 |
| Shareholders Funds | 27.530 | 20.175 | 7.801 | -4.306 | 5.744 | 10.675 | 15.383 | 13.439 | 14.732 | 9.371 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 345 | 442 | 419 | 6.562 | 1.296 | 178 | 167 | 207 | 149 | 176 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Medmida S.r.l.